Wilson Marc — SEC Form 4 filings
SEC reporting owner CIK 1702265. 6 Form 4 filings on record with FilingPulse; latest filed 2024-09-30.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-03-06 to 2024-09-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 108,127 shares, $5,378,514 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 32,129 shares @ $43.61 ($1,401,146) in Crinetics Pharmaceuticals, Inc., filed 2024-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | CFO | 6 | — | 5 legs · 108,127 sh · $5,378,514 | 11 |
Form 4 filings — Wilson Marc
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-09-30 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 25,000 @ $15.29 · Sale (S): 25,000 @ $51.11 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-07-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 19,056 @ $9.28 · Sale (S): 19,056 @ $53.88 · Option exercise (M): 19,056 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 25,000 @ $20.02 · Sale (S): 25,000 @ $55 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 32,129 @ $9.28 · Sale (S): 32,129 @ $43.61 · Option exercise (M): 32,129 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 3,983 @ $38.14 · Sale (S): 6,942 @ $42.91 | EDGAR |
| 2024-03-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 25,500 @ $0 · Grant/award (A): 95,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702265 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →